Guidelines for chemotherapy of biliary tract and ampullary carcinomas View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-01

AUTHORS

Junji Furuse, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Hiroya Saito, Toshio Tsuyuguchi, Koichi Hirata, Fumio Kimura, Hideyuki Yoshitomi, Satoshi Nozawa, Masahiro Yoshida, Keita Wada, Hodaka Amano, Fumihiko Miura

ABSTRACT

Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment. More... »

PAGES

55-62

References to SciGraph publications

  • 2005-09-02. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1999-02. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma in INVESTIGATIONAL NEW DRUGS
  • 2008-01. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 2004-04. Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer in INVESTIGATIONAL NEW DRUGS
  • 2005-04-26. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer in BRITISH JOURNAL OF CANCER
  • 2004-03-16. A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer in BRITISH JOURNAL OF CANCER
  • 2002-09-23. Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial in BRITISH JOURNAL OF CANCER
  • 2004-04-13. Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract in BRITISH JOURNAL OF CANCER
  • 2008-01-23. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2002-12. CPT-11 for bile-duct and gallbladder carcinoma in JOURNAL OF GASTROINTESTINAL CANCER
  • 2002-08. Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas in INVESTIGATIONAL NEW DRUGS
  • 2004-10-26. Phase II study of S-1 in patients with advanced biliary tract cancer in BRITISH JOURNAL OF CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z

    DOI

    http://dx.doi.org/10.1007/s00534-007-1280-z

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1017686721

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18274844


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ampulla of Vater", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biliary Tract Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chemotherapy, Adjuvant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Evidence-Based Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577 Japan", 
              "id": "http://www.grid.ac/institutes/grid.497282.2", 
              "name": [
                "Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Furuse", 
            "givenName": "Junji", 
            "id": "sg:person.01154650450.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154650450.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Takada", 
            "givenName": "Tadahiro", 
            "id": "sg:person.01145073410.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145073410.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miyazaki", 
            "givenName": "Masaru", 
            "id": "sg:person.0773025611.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773025611.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Gastroenterological Surgery, Fujita Health University, Toyoake, Japan", 
              "id": "http://www.grid.ac/institutes/grid.256115.4", 
              "name": [
                "Department of Gastroenterological Surgery, Fujita Health University, Toyoake, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miyakawa", 
            "givenName": "Shuichi", 
            "id": "sg:person.012517244744.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012517244744.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan", 
              "id": "http://www.grid.ac/institutes/grid.267346.2", 
              "name": [
                "Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tsukada", 
            "givenName": "Kazuhiro", 
            "id": "sg:person.01233146520.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233146520.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan", 
              "id": "http://www.grid.ac/institutes/grid.27476.30", 
              "name": [
                "Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nagino", 
            "givenName": "Masato", 
            "id": "sg:person.01211606464.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211606464.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.39158.36", 
              "name": [
                "Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kondo", 
            "givenName": "Satoshi", 
            "id": "sg:person.01264520473.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264520473.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiology, Asahikawa Kosei General Hospital, Asahikawa, Japan", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Radiology, Asahikawa Kosei General Hospital, Asahikawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Saito", 
            "givenName": "Hiroya", 
            "id": "sg:person.01245744760.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245744760.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chiba, Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chiba, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tsuyuguchi", 
            "givenName": "Toshio", 
            "id": "sg:person.0727433030.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727433030.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.263171.0", 
              "name": [
                "Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hirata", 
            "givenName": "Koichi", 
            "id": "sg:person.015313514313.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015313514313.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kimura", 
            "givenName": "Fumio", 
            "id": "sg:person.01127754745.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127754745.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yoshitomi", 
            "givenName": "Hideyuki", 
            "id": "sg:person.01245062664.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245062664.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan", 
              "id": "http://www.grid.ac/institutes/grid.136304.3", 
              "name": [
                "Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nozawa", 
            "givenName": "Satoshi", 
            "id": "sg:person.01267524127.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267524127.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yoshida", 
            "givenName": "Masahiro", 
            "id": "sg:person.01130041525.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130041525.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wada", 
            "givenName": "Keita", 
            "id": "sg:person.01162577627.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162577627.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Amano", 
            "givenName": "Hodaka", 
            "id": "sg:person.01167775323.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167775323.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.264706.1", 
              "name": [
                "Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miura", 
            "givenName": "Fumihiko", 
            "id": "sg:person.01115635730.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115635730.35"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.bjc.6601736", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016846770", 
              "https://doi.org/10.1038/sj.bjc.6601736"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:drug.0000011797.09549.53", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038864503", 
              "https://doi.org/10.1023/b:drug.0000011797.09549.53"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602576", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052616134", 
              "https://doi.org/10.1038/sj.bjc.6602576"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6601796", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008635604", 
              "https://doi.org/10.1038/sj.bjc.6601796"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1385/ijgc:32:2-3:107", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038909402", 
              "https://doi.org/10.1385/ijgc:32:2-3:107"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602208", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015354465", 
              "https://doi.org/10.1038/sj.bjc.6602208"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600543", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016551013", 
              "https://doi.org/10.1038/sj.bjc.6600543"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-007-0673-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013512506", 
              "https://doi.org/10.1007/s00280-007-0673-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00534-007-1274-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024299938", 
              "https://doi.org/10.1007/s00534-007-1274-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1016209901417", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015634355", 
              "https://doi.org/10.1023/a:1016209901417"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-005-0095-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030889660", 
              "https://doi.org/10.1007/s00280-005-0095-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1006268018519", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035563235", 
              "https://doi.org/10.1023/a:1006268018519"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2008-01", 
        "datePublishedReg": "2008-01-01", 
        "description": "Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00534-007-1280-z", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1043285", 
            "issn": [
              "1868-6974", 
              "1868-6982"
            ], 
            "name": "Journal of Hepato-Biliary-Pancreatic Sciences", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "15"
          }
        ], 
        "keywords": [
          "biliary tract cancer", 
          "unresectable biliary tract cancer", 
          "tract cancer", 
          "clinical trials", 
          "tegafur/gimeracil/oteracil potassium", 
          "postoperative adjuvant chemotherapy", 
          "multi-institutional RCTs", 
          "best supportive care", 
          "good general condition", 
          "benefit of chemotherapy", 
          "use of gemcitabine", 
          "effective adjuvant therapy", 
          "further clinical trials", 
          "quality of life", 
          "oteracil potassium", 
          "chemotherapy group", 
          "unresectable disease", 
          "biliary decompression", 
          "adjuvant chemotherapy", 
          "supportive care", 
          "advanced disease", 
          "performance status", 
          "adjuvant therapy", 
          "standard chemotherapy", 
          "distant metastasis", 
          "biliary tract", 
          "ampullary carcinoma", 
          "standard treatment", 
          "pathological diagnosis", 
          "histopathological diagnosis", 
          "novel agents", 
          "chemotherapy", 
          "patients", 
          "control group", 
          "cancer", 
          "significant treatment", 
          "diagnosis", 
          "trials", 
          "appropriate use", 
          "RCTs", 
          "gemcitabine", 
          "disease", 
          "care", 
          "treatment", 
          "general condition", 
          "general deterioration", 
          "guidelines", 
          "previous studies", 
          "resection", 
          "group", 
          "recurrence", 
          "carcinoma", 
          "metastasis", 
          "therapy", 
          "cytology", 
          "tract", 
          "decompression", 
          "survival", 
          "status", 
          "great care", 
          "agents", 
          "use", 
          "deterioration", 
          "present time", 
          "study", 
          "life", 
          "benefits", 
          "potassium", 
          "date", 
          "large number", 
          "quality", 
          "number", 
          "time", 
          "choice", 
          "conditions", 
          "article", 
          "order", 
          "rules", 
          "insufficient biliary decompression", 
          "gimeracil/oteracil potassium", 
          "large multi-institutional RCTs"
        ], 
        "name": "Guidelines for chemotherapy of biliary tract and ampullary carcinomas", 
        "pagination": "55-62", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1017686721"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00534-007-1280-z"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18274844"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00534-007-1280-z", 
          "https://app.dimensions.ai/details/publication/pub.1017686721"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-01-01T18:19", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_473.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00534-007-1280-z"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00534-007-1280-z'


     

    This table displays all metadata directly associated to this object as RDF triples.

    361 TRIPLES      22 PREDICATES      127 URIs      107 LITERALS      15 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00534-007-1280-z schema:about N39ca8ce05c60425eaa8b7be8d649ad05
    2 N4e9be8505d7a4e53863c70de647e6d3c
    3 N5da0e7e53b8644c8b4d73eeb81a09852
    4 N8665faf5d1ca4a0b906e1dd28ceb1bdf
    5 N93146bcb729441f893c6026d3b853803
    6 Na9ee7a6cddd440329098afbd42c63ea2
    7 Nb3c35afa7755471895f4b666c5c92213
    8 Nfada014678584644a255b5ee85dce7ae
    9 anzsrc-for:11
    10 anzsrc-for:1112
    11 schema:author N64d5c5ce2e9049e890df0d4da03ae785
    12 schema:citation sg:pub.10.1007/s00280-005-0095-3
    13 sg:pub.10.1007/s00280-007-0673-7
    14 sg:pub.10.1007/s00534-007-1274-x
    15 sg:pub.10.1023/a:1006268018519
    16 sg:pub.10.1023/a:1016209901417
    17 sg:pub.10.1023/b:drug.0000011797.09549.53
    18 sg:pub.10.1038/sj.bjc.6600543
    19 sg:pub.10.1038/sj.bjc.6601736
    20 sg:pub.10.1038/sj.bjc.6601796
    21 sg:pub.10.1038/sj.bjc.6602208
    22 sg:pub.10.1038/sj.bjc.6602576
    23 sg:pub.10.1385/ijgc:32:2-3:107
    24 schema:datePublished 2008-01
    25 schema:datePublishedReg 2008-01-01
    26 schema:description Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment.
    27 schema:genre article
    28 schema:inLanguage en
    29 schema:isAccessibleForFree true
    30 schema:isPartOf N56c696edbd5c4facaf3b33dadb4127e6
    31 Nf8c81efb9fcc4a319a0c5d595cde9cba
    32 sg:journal.1043285
    33 schema:keywords RCTs
    34 adjuvant chemotherapy
    35 adjuvant therapy
    36 advanced disease
    37 agents
    38 ampullary carcinoma
    39 appropriate use
    40 article
    41 benefit of chemotherapy
    42 benefits
    43 best supportive care
    44 biliary decompression
    45 biliary tract
    46 biliary tract cancer
    47 cancer
    48 carcinoma
    49 care
    50 chemotherapy
    51 chemotherapy group
    52 choice
    53 clinical trials
    54 conditions
    55 control group
    56 cytology
    57 date
    58 decompression
    59 deterioration
    60 diagnosis
    61 disease
    62 distant metastasis
    63 effective adjuvant therapy
    64 further clinical trials
    65 gemcitabine
    66 general condition
    67 general deterioration
    68 gimeracil/oteracil potassium
    69 good general condition
    70 great care
    71 group
    72 guidelines
    73 histopathological diagnosis
    74 insufficient biliary decompression
    75 large multi-institutional RCTs
    76 large number
    77 life
    78 metastasis
    79 multi-institutional RCTs
    80 novel agents
    81 number
    82 order
    83 oteracil potassium
    84 pathological diagnosis
    85 patients
    86 performance status
    87 postoperative adjuvant chemotherapy
    88 potassium
    89 present time
    90 previous studies
    91 quality
    92 quality of life
    93 recurrence
    94 resection
    95 rules
    96 significant treatment
    97 standard chemotherapy
    98 standard treatment
    99 status
    100 study
    101 supportive care
    102 survival
    103 tegafur/gimeracil/oteracil potassium
    104 therapy
    105 time
    106 tract
    107 tract cancer
    108 treatment
    109 trials
    110 unresectable biliary tract cancer
    111 unresectable disease
    112 use
    113 use of gemcitabine
    114 schema:name Guidelines for chemotherapy of biliary tract and ampullary carcinomas
    115 schema:pagination 55-62
    116 schema:productId N57afb4a2f9524c2fb7ca3f43bad0d0cd
    117 N88fd54e0e1894ceaaf0451988be3bfa0
    118 N8a3a59328b1847bcae148bcc43f2f7fc
    119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017686721
    120 https://doi.org/10.1007/s00534-007-1280-z
    121 schema:sdDatePublished 2022-01-01T18:19
    122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    123 schema:sdPublisher N4ea841dd6f764351b0db66274083db02
    124 schema:url https://doi.org/10.1007/s00534-007-1280-z
    125 sgo:license sg:explorer/license/
    126 sgo:sdDataset articles
    127 rdf:type schema:ScholarlyArticle
    128 N2b93ea81945343ffb4085af1e4aafb6f rdf:first sg:person.01130041525.07
    129 rdf:rest N663167a99fff445b8ef007f1600e43da
    130 N32c3145640b04447aa5da4c6371646d4 rdf:first sg:person.01245744760.47
    131 rdf:rest N3c00895b75534b71ae81ac6af2f48d9e
    132 N34ad3f06f73a4792a27b4e2d2e6a0dd5 rdf:first sg:person.015313514313.07
    133 rdf:rest Nd7c3b7d11a0c4cd8a5ae7bc8f50f70ce
    134 N39ca8ce05c60425eaa8b7be8d649ad05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Chemotherapy, Adjuvant
    136 rdf:type schema:DefinedTerm
    137 N3c00895b75534b71ae81ac6af2f48d9e rdf:first sg:person.0727433030.42
    138 rdf:rest N34ad3f06f73a4792a27b4e2d2e6a0dd5
    139 N42043e2fdadc4169affc3cccb8773cd7 rdf:first sg:person.0773025611.35
    140 rdf:rest Na72545e6efb743fe8e2db03b8042f4a1
    141 N42bd6ff13b254606acd3bf317516de4d rdf:first sg:person.01211606464.55
    142 rdf:rest N9a85a0ab5f9e40cabd2b005eb1d7b514
    143 N481a47f3a2c34731b8d2863e0cd90943 rdf:first sg:person.01145073410.03
    144 rdf:rest N42043e2fdadc4169affc3cccb8773cd7
    145 N4e9be8505d7a4e53863c70de647e6d3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Carcinoma
    147 rdf:type schema:DefinedTerm
    148 N4ea841dd6f764351b0db66274083db02 schema:name Springer Nature - SN SciGraph project
    149 rdf:type schema:Organization
    150 N56c696edbd5c4facaf3b33dadb4127e6 schema:volumeNumber 15
    151 rdf:type schema:PublicationVolume
    152 N57afb4a2f9524c2fb7ca3f43bad0d0cd schema:name doi
    153 schema:value 10.1007/s00534-007-1280-z
    154 rdf:type schema:PropertyValue
    155 N5da0e7e53b8644c8b4d73eeb81a09852 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Evidence-Based Medicine
    157 rdf:type schema:DefinedTerm
    158 N5ed711088edd4e4b9e4b5363f27fa70b rdf:first sg:person.01167775323.13
    159 rdf:rest N7026422613964a1082020a06d04801b8
    160 N64d5c5ce2e9049e890df0d4da03ae785 rdf:first sg:person.01154650450.78
    161 rdf:rest N481a47f3a2c34731b8d2863e0cd90943
    162 N663167a99fff445b8ef007f1600e43da rdf:first sg:person.01162577627.41
    163 rdf:rest N5ed711088edd4e4b9e4b5363f27fa70b
    164 N7026422613964a1082020a06d04801b8 rdf:first sg:person.01115635730.35
    165 rdf:rest rdf:nil
    166 N8665faf5d1ca4a0b906e1dd28ceb1bdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Randomized Controlled Trials as Topic
    168 rdf:type schema:DefinedTerm
    169 N88fd54e0e1894ceaaf0451988be3bfa0 schema:name pubmed_id
    170 schema:value 18274844
    171 rdf:type schema:PropertyValue
    172 N8a3a59328b1847bcae148bcc43f2f7fc schema:name dimensions_id
    173 schema:value pub.1017686721
    174 rdf:type schema:PropertyValue
    175 N93146bcb729441f893c6026d3b853803 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Antineoplastic Agents
    177 rdf:type schema:DefinedTerm
    178 N9a85a0ab5f9e40cabd2b005eb1d7b514 rdf:first sg:person.01264520473.17
    179 rdf:rest N32c3145640b04447aa5da4c6371646d4
    180 Na72545e6efb743fe8e2db03b8042f4a1 rdf:first sg:person.012517244744.16
    181 rdf:rest Ne541e27e59494c2fa80ae83c9078990c
    182 Na9ee7a6cddd440329098afbd42c63ea2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Ampulla of Vater
    184 rdf:type schema:DefinedTerm
    185 Nb3c35afa7755471895f4b666c5c92213 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Humans
    187 rdf:type schema:DefinedTerm
    188 Nd4a63e06659d491d959c6822ec3274bb rdf:first sg:person.01245062664.63
    189 rdf:rest Nf944e94994b04b8eb3a1873b4aaf40e8
    190 Nd7c3b7d11a0c4cd8a5ae7bc8f50f70ce rdf:first sg:person.01127754745.32
    191 rdf:rest Nd4a63e06659d491d959c6822ec3274bb
    192 Ne541e27e59494c2fa80ae83c9078990c rdf:first sg:person.01233146520.29
    193 rdf:rest N42bd6ff13b254606acd3bf317516de4d
    194 Nf8c81efb9fcc4a319a0c5d595cde9cba schema:issueNumber 1
    195 rdf:type schema:PublicationIssue
    196 Nf944e94994b04b8eb3a1873b4aaf40e8 rdf:first sg:person.01267524127.30
    197 rdf:rest N2b93ea81945343ffb4085af1e4aafb6f
    198 Nfada014678584644a255b5ee85dce7ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Biliary Tract Neoplasms
    200 rdf:type schema:DefinedTerm
    201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    202 schema:name Medical and Health Sciences
    203 rdf:type schema:DefinedTerm
    204 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    205 schema:name Oncology and Carcinogenesis
    206 rdf:type schema:DefinedTerm
    207 sg:journal.1043285 schema:issn 1868-6974
    208 1868-6982
    209 schema:name Journal of Hepato-Biliary-Pancreatic Sciences
    210 schema:publisher Springer Nature
    211 rdf:type schema:Periodical
    212 sg:person.01115635730.35 schema:affiliation grid-institutes:grid.264706.1
    213 schema:familyName Miura
    214 schema:givenName Fumihiko
    215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115635730.35
    216 rdf:type schema:Person
    217 sg:person.01127754745.32 schema:affiliation grid-institutes:grid.136304.3
    218 schema:familyName Kimura
    219 schema:givenName Fumio
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127754745.32
    221 rdf:type schema:Person
    222 sg:person.01130041525.07 schema:affiliation grid-institutes:grid.264706.1
    223 schema:familyName Yoshida
    224 schema:givenName Masahiro
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130041525.07
    226 rdf:type schema:Person
    227 sg:person.01145073410.03 schema:affiliation grid-institutes:grid.264706.1
    228 schema:familyName Takada
    229 schema:givenName Tadahiro
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145073410.03
    231 rdf:type schema:Person
    232 sg:person.01154650450.78 schema:affiliation grid-institutes:grid.497282.2
    233 schema:familyName Furuse
    234 schema:givenName Junji
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154650450.78
    236 rdf:type schema:Person
    237 sg:person.01162577627.41 schema:affiliation grid-institutes:grid.264706.1
    238 schema:familyName Wada
    239 schema:givenName Keita
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162577627.41
    241 rdf:type schema:Person
    242 sg:person.01167775323.13 schema:affiliation grid-institutes:grid.264706.1
    243 schema:familyName Amano
    244 schema:givenName Hodaka
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167775323.13
    246 rdf:type schema:Person
    247 sg:person.01211606464.55 schema:affiliation grid-institutes:grid.27476.30
    248 schema:familyName Nagino
    249 schema:givenName Masato
    250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211606464.55
    251 rdf:type schema:Person
    252 sg:person.01233146520.29 schema:affiliation grid-institutes:grid.267346.2
    253 schema:familyName Tsukada
    254 schema:givenName Kazuhiro
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233146520.29
    256 rdf:type schema:Person
    257 sg:person.01245062664.63 schema:affiliation grid-institutes:grid.136304.3
    258 schema:familyName Yoshitomi
    259 schema:givenName Hideyuki
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245062664.63
    261 rdf:type schema:Person
    262 sg:person.01245744760.47 schema:affiliation grid-institutes:None
    263 schema:familyName Saito
    264 schema:givenName Hiroya
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245744760.47
    266 rdf:type schema:Person
    267 sg:person.012517244744.16 schema:affiliation grid-institutes:grid.256115.4
    268 schema:familyName Miyakawa
    269 schema:givenName Shuichi
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012517244744.16
    271 rdf:type schema:Person
    272 sg:person.01264520473.17 schema:affiliation grid-institutes:grid.39158.36
    273 schema:familyName Kondo
    274 schema:givenName Satoshi
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264520473.17
    276 rdf:type schema:Person
    277 sg:person.01267524127.30 schema:affiliation grid-institutes:grid.136304.3
    278 schema:familyName Nozawa
    279 schema:givenName Satoshi
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267524127.30
    281 rdf:type schema:Person
    282 sg:person.015313514313.07 schema:affiliation grid-institutes:grid.263171.0
    283 schema:familyName Hirata
    284 schema:givenName Koichi
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015313514313.07
    286 rdf:type schema:Person
    287 sg:person.0727433030.42 schema:affiliation grid-institutes:grid.136304.3
    288 schema:familyName Tsuyuguchi
    289 schema:givenName Toshio
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727433030.42
    291 rdf:type schema:Person
    292 sg:person.0773025611.35 schema:affiliation grid-institutes:grid.136304.3
    293 schema:familyName Miyazaki
    294 schema:givenName Masaru
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773025611.35
    296 rdf:type schema:Person
    297 sg:pub.10.1007/s00280-005-0095-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030889660
    298 https://doi.org/10.1007/s00280-005-0095-3
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1007/s00280-007-0673-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013512506
    301 https://doi.org/10.1007/s00280-007-0673-7
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1007/s00534-007-1274-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024299938
    304 https://doi.org/10.1007/s00534-007-1274-x
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1023/a:1006268018519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035563235
    307 https://doi.org/10.1023/a:1006268018519
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1023/a:1016209901417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015634355
    310 https://doi.org/10.1023/a:1016209901417
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1023/b:drug.0000011797.09549.53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038864503
    313 https://doi.org/10.1023/b:drug.0000011797.09549.53
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/sj.bjc.6600543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016551013
    316 https://doi.org/10.1038/sj.bjc.6600543
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1038/sj.bjc.6601736 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016846770
    319 https://doi.org/10.1038/sj.bjc.6601736
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1038/sj.bjc.6601796 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008635604
    322 https://doi.org/10.1038/sj.bjc.6601796
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1038/sj.bjc.6602208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015354465
    325 https://doi.org/10.1038/sj.bjc.6602208
    326 rdf:type schema:CreativeWork
    327 sg:pub.10.1038/sj.bjc.6602576 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052616134
    328 https://doi.org/10.1038/sj.bjc.6602576
    329 rdf:type schema:CreativeWork
    330 sg:pub.10.1385/ijgc:32:2-3:107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038909402
    331 https://doi.org/10.1385/ijgc:32:2-3:107
    332 rdf:type schema:CreativeWork
    333 grid-institutes:None schema:alternateName Department of Radiology, Asahikawa Kosei General Hospital, Asahikawa, Japan
    334 schema:name Department of Radiology, Asahikawa Kosei General Hospital, Asahikawa, Japan
    335 rdf:type schema:Organization
    336 grid-institutes:grid.136304.3 schema:alternateName Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
    337 Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chiba, Japan
    338 schema:name Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
    339 Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chiba, Japan
    340 rdf:type schema:Organization
    341 grid-institutes:grid.256115.4 schema:alternateName Department of Gastroenterological Surgery, Fujita Health University, Toyoake, Japan
    342 schema:name Department of Gastroenterological Surgery, Fujita Health University, Toyoake, Japan
    343 rdf:type schema:Organization
    344 grid-institutes:grid.263171.0 schema:alternateName Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    345 schema:name Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan
    346 rdf:type schema:Organization
    347 grid-institutes:grid.264706.1 schema:alternateName Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
    348 schema:name Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
    349 rdf:type schema:Organization
    350 grid-institutes:grid.267346.2 schema:alternateName Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan
    351 schema:name Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan
    352 rdf:type schema:Organization
    353 grid-institutes:grid.27476.30 schema:alternateName Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
    354 schema:name Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
    355 rdf:type schema:Organization
    356 grid-institutes:grid.39158.36 schema:alternateName Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    357 schema:name Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    358 rdf:type schema:Organization
    359 grid-institutes:grid.497282.2 schema:alternateName Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577 Japan
    360 schema:name Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577 Japan
    361 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...